======= BABAM1 ======= == Gene Information == * **Official Symbol**: BABAM1 * **Official Name**: BRISC and BRCA1 A complex member 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29086|29086]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NWV8|Q9NWV8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BABAM1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BABAM1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612766|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the BRCA1-A complex, a complex that specifically recognizes 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. In the BRCA1-A complex, it is required for the complex integrity and its localization at DSBs. Component of the BRISC complex, a multiprotein complex that specifically cleaves 'Lys- 63'-linked ubiquitin in various substrates (PubMed:24075985, PubMed:26195665). In these 2 complexes, it is probably required to maintain the stability of BABAM2 and help the 'Lys-63'-linked deubiquitinase activity mediated by BRCC3/BRCC36 component. The BRISC complex is required for normal mitotic spindle assembly and microtubule attachment to kinetochores via its role in deubiquitinating NUMA1 (PubMed:26195665). Plays a role in interferon signaling via its role in the deubiquitination of the interferon receptor IFNAR1; deubiquitination increases IFNAR1 activity by enhancing its stability and cell surface expression (PubMed:24075985). Down-regulates the response to bacterial lipopolysaccharide (LPS) via its role in IFNAR1 deubiquitination (PubMed:24075985). {ECO:0000269|PubMed:19261746, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19261749}. No Pfam Domain information is available for this gene. |BRISC complex| |BRCA1-A complex| |signal transduction involved in G2 DNA damage checkpoint| |hematopoietic stem cell proliferation| |G2 DNA damage checkpoint| |protein K63-linked deubiquitination| |stem cell proliferation| |double-strand break repair via nonhomologous end joining| |non-recombinational repair| |positive regulation of DNA repair| |signal transduction involved in DNA damage checkpoint| |signal transduction involved in DNA integrity checkpoint| |signal transduction involved in cell cycle checkpoint| |positive regulation of response to DNA damage stimulus| |negative regulation of cell cycle G2/M phase transition| |signal transduction in response to DNA damage| |regulation of DNA repair| |DNA damage checkpoint| |DNA integrity checkpoint| |response to ionizing radiation| |double-strand break repair| |cell cycle checkpoint| |positive regulation of DNA metabolic process| |regulation of cell cycle G2/M phase transition| |regulation of response to DNA damage stimulus| |negative regulation of cell cycle phase transition| |protein deubiquitination| |nuclear body| |protein modification by small protein removal| |negative regulation of cell cycle process| |regulation of DNA metabolic process| |response to radiation| |regulation of cell cycle phase transition| |cell division| |DNA repair| |cell population proliferation| |hemopoiesis| |negative regulation of cell cycle| |hematopoietic or lymphoid organ development| |immune system development| |chromatin organization| |regulation of cellular response to stress| |DNA metabolic process| |regulation of cell cycle process| |cellular response to DNA damage stimulus| |protein modification by small protein conjugation or removal| |chromosome organization| |response to abiotic stimulus| |regulation of cell cycle| |proteolysis| |cell cycle| |regulation of response to stress| |intracellular signal transduction| |cellular response to stress| |positive regulation of nucleobase-containing compound metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-2.21| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-2.03| |[[:results:exp485|GSK626616 14μM R08 exp485]]|1.93| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10119 * **Expression level (log2 read counts)**: 5.84 {{:chemogenomics:nalm6 dist.png?nolink |}}